Proapoptotic BH3-only protein bid is essential for death receptor-induced apoptosis of pancreatic β-cells

Diabetes

Volumn 57, Issue 5, 2008, Pages 1284-1292

  McKenzie, Mark D ^a   Carrington, Emma M ^a   Kaufmann, Thomas ^b   Strasser, Andreas ^b   Huang, David C S ^b   Kay, Thomas W H ^a   Allison, Janette ^a   Thomas, Helen E ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEATH RECEPTOR; ETOPOSIDE; FAS LIGAND; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; STAUROSPORINE; THAPSIGARGIN; TUMOR NECROSIS FACTOR ALPHA; TUNICAMYCIN; BID PROTEIN, MOUSE; CYTOCHROME C; INTERFERON; INTERLEUKIN 1BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; GAMMA RADIATION; HUMAN; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL DEATH; CYTOLOGY; DRUG EFFECT; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; METABOLISM; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL DEATH; CYTOCHROMES C; GLUCOSE TOLERANCE TEST; INSULIN-SECRETING CELLS; INTERFERONS; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, DEATH DOMAIN;

EID: 48449089654     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1692     Document Type: Article

References (49)

1. Mathis D, Vence L, Benoist C: Beta-cell death during progression to diabetes. Nature 414:792-798, 2001
2. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL: Mechanisms of pancreatic p-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 (Suppl 2):S97-S107, 2005
3. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: p-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110, 2003
4. Bernard-Kargar C, Ktorza A: Endocrine pancreas plasticity under physiological and pathological conditions. Diabetes 50 (Suppl 1):S30-S35, 2001
5. Emamaullee JA, Shapiro AM: Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant 16:1-8, 2007
6. Marsden VS, Strasser A: Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 21:71-105, 2003
7. Krammer PH: CD95's deadly mission in the immune system. Nature 407:789-795, 2000
8. Strasser A: The role of BH3-only proteins in the immune system. Nat Rev Immunol 5:189-200, 2005
9. Huang DC, Strasser A: BH3-only proteins: essential initiators of apoptotic cell death. Cell 103:839-842, 2000
10. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE, Ierino H, Lee EF, Fairlie WD, Bouillet P, Strasser A, Kluck RM, Adams JM, Huang DC: Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315:856-859, 2007
11. Li H, Zhu H, Xu CJ, Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501, 1998
12. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490, 1998
13. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P, Korsmeyer SJ: Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274:1156-1163, 1999
14. Waterhouse NJ, Sedelies KA, Browne KA, Wowk ME, Newbold A, Sutton VR, Clarke CJ, Oliaro J, Lindemann RK, Bird PI, Johnstone RW, Trapani JA: A central role for Bid in granzyme B-induced apoptosis. J Biol Chem 280:4476-4482, 2005
15. Estella E, McKenzie MD, Catterall T, Sutton VR, Bird PI, Trapani JA, Kay TW, Thomas HE: Granzyme B-mediated death of pancreatic β-cells requires the proapoptotic BH3-only molecule bid. Diabetes 55:2212-2219, 2006
16. Yin XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA, Korsmeyer SJ: Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400:886-891, 1999
17. Kaufmann T, Tai L, Ekert PG, Huang DC, Norris F, Lindemann RK, Johnstone RW, Dixit VM, Strasser A: The BH3-only protein bid is dispensable for DNA damage-and replicative stress-induced apoptosis or cell-cycle arrest. Cell 129:423-433, 2007
18. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME: Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274:22532-22538, 1999
19. Allison J, Thomas H, Beck D, Brady JL, Lew AM, Elefanty A, Kosaka H, Kay TW, Huang DC, Strasser A: Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction. Int Immunol 12:9-17, 2000
20. Allison J, Thomas HE, Catterall T, Kay TW, Strasser A: Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice. J Immunol 175:293-301, 2005
21. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96-99, 1995
22. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E, Waymire KG, Mahar P, Frauwirth K, Chen Y, Wei M, Eng VM, Adelman DM, Simon MC, Ma A, Golden JA, Evan G, Korsmeyer SJ, MacGregor GR, Thompson CB: The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 6:1389-1399, 2000
23. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, Huang DC: Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19:1294-1305, 2005
24. McKenzie MD, Dudek NL, Mariana L, Chong MM, Trapani JA, Kay TW, Thomas HE: Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL. Int Immunol 18:837-846, 2006
25. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279, 1991
26. Waterhouse NJ, Trapani JA: A new quantitative assay for cytochrome c release in apoptotic cells. Cell Death Differ 10:853-855, 2003
27. Yin XM: Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 369:7-19, 2006
28. Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L, Haimovich G, Lerenthal Y, Marcellus RC, Gross A: Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 122:593-603, 2005
29. Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ: A role for proapoptotic BID in the DNA-damage response. Cell 122:579-591, 2005
30. Jimbo A, Fujita E, Kouroku Y, Ohnishi J, Inohara N, Kuida K, Sakamaki K, Yonehara S, Momoi T: ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. Exp Cell Res 283:156-166, 2003
31. Kaufmann T, Tai L, Ekert PG, Huang DC, Norris F, Lindemann RK, Johnstone RW, Dixit VM, Arnoult D, Strasser A: Response: does bid play a role in the DNA damage response? Cell 130:10-11, 2007
32. Harding HP, Ron D: Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 51 (Suppl 3):S455-S461, 2002
33. Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, Homann D, Beaudoin L, Schrike C, Von Herrath M, Lehuen A, Glaichenhaus N: Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity 16:169-181, 2002
34. Thomas HE, Darwiche R, Corbett JA, Kay TW: Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. J Immunol 163:1562-1569, 1999
35. van Delft MF, Huang DC: How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 16:203-213, 2006
36. Aggarwal BB: Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3:745-756, 2003
37. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730, 2001
38. Pradhan S, Genebriera J, Denning WL, Felix K, Elmets CA, Timares L: CD4 T cell-induced, bid-dependent apoptosis of cutaneous dendritic cells regulates T cell expansion and immune responses. J Immunol 177:5956-5967, 2006
39. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V, Kahn A: Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 2:80-86, 1996
40. Rodriguez I, Matsuura K, Khatib K, Reed JC, Nagata S, Vassalli P: A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J Exp Med 183:1031-1036, 1996
41. Puthalakath H, O'Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND, Hughes PD, Michalak EM, McKimm-Breschkin J, Motoyama N, Gotoh T, Akira S, Bouillet P, Strasser A: ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129:1337-1349, 2007
42. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ, Adams JM, Strasser A: p53-and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302:1036-1038, 2003
43. Kagi D, Odermatt B, Seiler P, Zinkernagel RM, Mak TW, Hengartner H: Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med 186:989-997, 1997
44. Dudek NL, Thomas HE, Mariana L, Sutherland RM, Allison J, Estella E, Angstetra E, Trapani JA, Santamaria P, Lew AM, Kay TW: Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy β-cells via the perforin and Fas pathways. Diabetes 55:2412-2418, 2006
45. Hui H, Khoury N, Zhao X, Balkir L, D'Amico E, Bullotta A, Nguyen ED, Gambotto A, Perfetti R: Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. Diabetes 54:424-433, 2005
46. Emamaullee JA, Rajotte RV, Liston P, Korneluk RG, Lakey JR, Shapiro AM, Elliott JF: XIAP overexpression in human islets prevents early posttrans-plant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes 54:2541-2548, 2005
47. Colell A, Ricci JE, Tait S, Milasta S, Maurer U, Bouchier-Hayes L, Fitzgerald P, Guio-Carrion A, Waterhouse NJ, Li CW, Mari B, Barbry P, Newmeyer DD, Beere HM, Green DR: GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 129:983-997, 2007
48. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM, Strasser A: Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419:634-637, 2002
49. Becattini B, Culmsee C, Leone M, Zhai D, Zhang X, Crowell KJ, Rega MF, Landshamer S, Reed JC, Plesnila N, Pellecchia M: Structure-activity relationships by interligand NOE-based design and synthesis of antiapop-totic compounds targeting Bid. Proc Natl Acad Sci USA 103:12602-12606, 2006